Bokemeyer B, Plachta-Danielzik S, di Giuseppe R, Efken P, et al. Real-world effectiveness of vedolizumab compared to anti-TNF agents in biologic-naive patients with ulcerative colitis: A two-year propensity-score-adjusted analysis from the prospective, observational VEDO(IBD) -study. Aliment Pharmacol Ther 2023 Jun 15. doi: 10.1111/apt.17616.
PMID: 37322825